id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0539-0054,FDA,FDA-2009-D-0539,"Immunogenicity Testing of Therapeutic Protein Products—Developing and Validating Assays for Anti-Drug Antibody Detection; Guidance for
Industry; Availability",Notice,Notice of Availability,2019-02-01T05:00:00Z,2019,2,2019-02-01T05:00:00Z,,2019-02-01T14:56:05Z,2019-00666,0,0,0900006483a32a52
FDA-2009-D-0539-0055,FDA,FDA-2009-D-0539,"Immunogenicity Testing of Therapeutic Protein Products - Developing and Validating Assays for Anti-Drug Antibody Detection; Guidance for
Industry; Availability",Other,Guidance,2019-02-01T05:00:00Z,2019,2,2019-02-01T05:00:00Z,,2024-11-12T22:54:51Z,,1,0,0900006483a33009